Medication Recall Alert Sabril® (Vigabatrin)

September 7, 2023
Our friends at the Epielpsy Foundation have shared the Following Medication Recall
The company that makes Sabril® (vigabatrin) for oral solution, a prescription medication to manage seizures in children and adults, has announced a recall of this medication because of possible trace amounts of another prescription drug in Sabril. The recall will likely impact the availability of Sabril. Please be advised not to discontinue Sabril for oral solution without consulting with your doctor first. The risk of suddenly stopping the medication is higher than the potential risk of trace contamination, which is low. For more information on the lots affected, please call 1-866-402-8520 or email medicalinformation@lundbeck.com.

Related Posts

MEDICATION ALERT – FELBAMATE (Generic)

MEDICATION ALERT – FELBAMATE (Generic)

We understand that some families in our community may be having challenges getting prescriptions filled for generic Felbamate oral suspension and tablets. If you need assistance with obtaining your medication, contact our 24/7 Helpline at 1-800-332-1000 for connection...

Medicaid Eligibility Renewals are Coming!

Medicaid Eligibility Renewals are Coming!

Medicaid Eligibility Renewals are Coming! Medicaid eligibility renewals were paused during the COVID-19 pandemic but are re-starting soon. This means that almost everyone on Medicaid in the US will need to renew their eligibility at some point between February 2023...

Target Recalls Children’s Pillowfort Weighted Blankets

Target Recalls Children’s Pillowfort Weighted Blankets

Target Recalls Children’s Pillowfort Weighted Blankets Due to Asphyxiation Hazard; Two Fatalities Reported The U.S. Consumer Product Safety Commission (CPSC) and Target Corporation, of Minneapolis, Minnesota, are announcing the recall of about 204,000 Pillowfort...